Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Global Journal of Endocrinological Metabolism

Hyperparathyroidism and Asthenia. A New Deal?
  • Open or Close Li Sun Fui S* and SP Bonnichon

    French Institute of Endocrine Surgery, Ramsay General Health - Private Hospital of the Poplars (HPP), France

    *Corresponding author: S. Li Sun Fui, French Institute of Endocrine Surgery, Ramsay General Health - Private Hospital of the Poplars (HPP), 8 place of the abbot G Hénocque 75013 Paris, France, Email: lisunfui@gmail.com

Submission: November 06, 2017; Published: December 21, 2017

Volume1 Issue3
December 2017

Abstract

The profile of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptoms and in some cases totally asymptomatic forms. As of 1991, with the increasing frequency of these new forms, several consensus meetings designed to define the criteria for establishing the operability of minimally-symptomatic hyperparathyroidism have been organized [1]. However, the criteria chosen are in some cases deemed too restrictive as they do not take into account general and neuro-psychic symptoms which are frequently associated [2].

Get access to the full text of this article


About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • Third Avenue, 2nd floor,
  •     New York - 10016, USA
  • +1 (929) 600-8049
  • +1 (929) 296-7519
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com

Editorial Office